Engineering of SauriCas9 with enhanced specificity
SauriCas9 is a compact Cas9 nuclease showing promise for in vivo therapeutic applications. However, concerns about off-target effects necessitated improvements in specificity. We addressed this by introducing mutations to eliminate polar contacts between Cas9 and the target DNA, resulting in the Sau...
Saved in:
Main Authors: | Xiaoqi Zhang, Chen Tao, Miaomiao Li, Sufang Zhang, Puping Liang, Yan Huang, Huihui Liu, Yongming Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253125000095 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Flexibility in PAM recognition expands DNA targeting in xCas9
by: Kazi A Hossain, et al.
Published: (2025-02-01) -
Synergistic strategies for glioblastoma treatment: CRISPR-based multigene editing combined with immune checkpoint blockade
by: Xiaolin Liu, et al.
Published: (2025-02-01) -
From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseases
by: Qing Zhao, et al.
Published: (2025-03-01) -
Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
by: Fatemeh Dehghan, et al.
Published: (2025-02-01) -
Induced protein expression in Leptospira spp. and its application to CRISPR/Cas9 mutant generation
by: L. G. V. Fernandes, et al.
Published: (2025-02-01)